Fact Sheet: Copper Sulfate INAD 9101

for detailed information, see INAD study protocol, use link on the left
last updated: 1 December 2011

The following links are specific to:
Copper Sulfate

Drug summary & history

List of FDA-Approved drugs

INAD study protocol

Material Safety Data Sheet
(MSDS)

What's the status of this drug's
approval

Print this drug fact sheet

Print all drug fact sheets

Sign-up via the INAD Program Management System (IPMS)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Authorization & Categorical Exclusion Letters

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of copper sulfate to control external protozoan and metazoan parasites, and bacterial and fungal infections in a variety of warmwater fish species.
Drug name: Copper sulfate
Source of drug: Freeport-McMoRan
Address: P.O Box 20001 El Paso, TX 79998
Contact: David Fisher
Phone: 915.782.7421
email: david_fisher@fmi.com
webpage: http://www.fcx.com/metals/copper_sulfate.htm
Target pathogen(s): external parasites, bacteria, and fungi
Method of administration: Immersion: standing-bath or flow-through treatment
Treatment dosage: Variable (dependent upon total alkalinity). See Study Protocol for calculations.
Treatment regimen:

Treatment duration is 1 hour.

Although a single treatment event is generally efficacious, repeated treatments may be used.

Withdrawal period:

7 days

No withdrawal period is required for fish that are not susceptible to legal harvest for a period of 7 days post-treatment.

Required test parameters: Investigator must collect data indicating pre-treatment pathogen level, and pathogen level at 1, 4, and 18 hours post-treatment. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Limitations or restrictions on use:

Investigator must follow all instructions in the Study Protocol for INAD 9101 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Drug discharge must be in compliance with local NPDES permitting requirements.

Required INAD fee: none
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

email: bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.